Filter News
Area of Research
- (-) Biology and Environment (14)
- (-) Fusion Energy (1)
- Advanced Manufacturing (2)
- Clean Energy (34)
- Computer Science (3)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (5)
- Isotopes (1)
- Materials (33)
- Materials for Computing (3)
- National Security (17)
- Neutron Science (46)
- Nuclear Science and Technology (6)
- Quantum information Science (1)
- Sensors and Controls (1)
- Supercomputing (33)
News Type
News Topics
- (-) Advanced Reactors (2)
- (-) Artificial Intelligence (3)
- (-) Coronavirus (7)
- (-) Cybersecurity (1)
- (-) Decarbonization (2)
- (-) Neutron Science (3)
- (-) Security (1)
- 3-D Printing/Advanced Manufacturing (7)
- Big Data (1)
- Bioenergy (9)
- Biology (18)
- Biomedical (5)
- Biotechnology (5)
- Buildings (2)
- Chemical Sciences (8)
- Climate Change (7)
- Composites (3)
- Computer Science (5)
- Critical Materials (1)
- Energy Storage (5)
- Environment (15)
- Fusion (3)
- Grid (1)
- High-Performance Computing (5)
- Isotopes (2)
- Machine Learning (2)
- Materials (10)
- Materials Science (4)
- Microscopy (3)
- Molten Salt (1)
- Nanotechnology (5)
- National Security (1)
- Net Zero (1)
- Nuclear Energy (2)
- Partnerships (5)
- Physics (1)
- Polymers (1)
- Simulation (4)
- Summit (3)
- Sustainable Energy (4)
- Transformational Challenge Reactor (1)
- Transportation (2)
Media Contacts
The annual Director's Awards recognized four individuals and teams including awards for leadership in quantum simulation development and application on high-performance computing platforms, and revolutionary advancements in the area of microbial
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
A team led by Dan Jacobson of Oak Ridge National Laboratory used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.
Researchers at the Department of Energy’s Oak Ridge National Laboratory have used Summit, the world’s most powerful and smartest supercomputer, to identify 77 small-molecule drug compounds that might warrant further study in the fight
The U.S. Department of Energy announced funding for 12 projects with private industry to enable collaboration with DOE national laboratories on overcoming challenges in fusion energy development.